Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are currently receiving services, or are eligible to receive services, at the sites where the trial is recruiting
- People who can read and speak English
- People who are at least 50 years old
- People who have at least moderate symptoms of depression at the screening stage, as measured by a standard questionnaire called the PHQ-9 (a score of 8 or higher)
- People who are not currently in therapy outside the trial must agree not to start any outside therapy while taking part; people who are already in outside therapy must agree not to increase how often those sessions occur during the study
Who may not be able to join:
- People who show signs of probable dementia, based on a memory and orientation assessment
- People who are assessed as being at moderate or high risk of suicide, based on a standard rating scale
- People who have a terminal illness with less than six months to live, or who have unstable physical health conditions (based on self-report)
- People who have been diagnosed with a psychotic disorder such as schizophrenia or bipolar disorder (based on self-report and medical records)
- People with severe vision impairment, including those who are legally blind (based on self-report)
- People who currently have a substance use disorder or who are currently receiving treatment for substance use
- People who are currently receiving outside therapy more than once a month, or who started a new therapy treatment less than three months ago
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiaoling Xiang, PhD, University of Michigan
Phone: 734-763-6581
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Patient Health Questionnaire-9 (PHQ-9)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.